Company / Free Cash Flow
Vericel Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$24.7M
FY2025
5-year range
-$9.8M / $24.7M
FY2021-FY2025
Trend
+525.9%
vs FY2024
Sector context
#62 of 194
Health Care
What the data says
Free Cash Flow changed +526% YoY in FY2025, a notable deviation from the 9-year average annual change of +60%.
Based on SEC 10-K filings.
$25M in FY2025 with a 3-year CAGR of +18.3%.
Improved from $15M to $25M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +18.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#62 of 194 in Health CareTop 32% of 194This company $24.7M Sector average $470.6M
▼
-94.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +18.3%, indicating consistent growth.
- In FY2025, free cash flow increased 525.9% year-over-year.
- Ranks #62 out of 194 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.7M | +525.9% |
| FY2024 | -$5.8M | -138.0% |
| FY2023 | $15.3M | +2.4% |
| FY2022 | $14.9M | +252.5% |
| FY2021 | -$9.8M | -217.1% |
| FY2020 | -$3.1M | +79.0% |
| FY2019 | -$14.7M | +31.0% |
| FY2018 | -$21.3M | -35.1% |
| FY2017 | -$15.8M | +39.9% |
| FY2016 | -$26.2M | -31.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026